The Future of Food Allergy Management: Advancements in Therapies

Idil D. Ezhuthachan,Michele Beaudoin,Anna Nowak-Wegrzyn,Brian P. Vickery
DOI: https://doi.org/10.1007/s11882-024-01133-1
2024-02-24
Current Allergy and Asthma Reports
Abstract:To review current and future treatment options for IgE-mediated food allergy. Recent years have seen major developments in both allergen-specific and allergen-non-specific treatment options, with the first FDA-approved peanut oral immunotherapy (OIT) product becoming available in 2020. In addition to OIT, other immunotherapy modalities, biologics, adjunct therapies, and novel therapeutics are under investigation.
immunology,allergy
What problem does this paper attempt to address?